1. Search Result
Search Result
Results for "


" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-139970

    Androgen Receptor Cancer Endocrinology
    VPC-13789 is a potent, selective, and orally bioavailable antiandrogen. VPC-13789 can be used for the research of castration-resistant prostate cancer (CRPC) therapeutics. VPC-13789 inhibits androgen receptor (AR) transcriptional activity in LNCaP cells (IC50=0.19 μM).